Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
53.2 EUR | -1.85% |
|
+2.68% | -4.79% |
18/06 | Borse Frankfurt-News: Many winners and many losers (second-line stocks) | DP |
13/06 | Formycon Starts Clinical Trials of Keytruda Biosimilar Candidate for Skin Cancer Therapy | MT |
Analyst Reco.
- Stock Market
- Equities
- FYB Stock
- News Formycon AG
- Analyst Reco.